Miklos Salgo, M.D., Ph.D.

Dr. Miklos Salgo is a Clinical Science Leader - Fuzeon and Director of Clinical Virology (HIV/AIDS) at Roche.  Dr. Salgo was the lead scientist for the clinical development of several new drug treatments for HIV/AIDS for the company.  This includes the development of HIVID® (zalcitabine, ddC), one of the first AIDS drugs, and Invirase®/Fortovase® (saquinavir), the first protease inhibitor approved for the treatment of HIV. These drugs, together with others antiretroviral treatments, make up the "drug cocktails," which led to the dramatic decreases in HIV/AIDS mortality during the last seven years. More recently, Dr. Salgo led the team that successfully developed Fuzeon® (enfuvirtide), the first of a new class of drugs called fusion inhibitors, which are designed to be active for patients who are failing current therapies.

Along the way, partly because he realized their input would be valuable to his clinical programs and partly because he knew they needed to be heard, Dr. Salgo fostered groundbreaking relationships with an often critical and vocal AIDS activist community. Early on, he recognized that a successful clinical study not only needed to demonstrate the safety and efficacy of a compound, it also needed to be patient friendly to insure compliance. Over the years, Dr. Salgo’s efforts with patient groups and in providing education on the diseases and treatments has made a difference in tens of thousands of lives and also allowed Roche to improve its HIV clinical trial process.

In recognition of his efforts, in October, 2002, Dr. Salgo received the Ann Klein Advocate Award from the Community Health Law Project in New Jersey, for his groundbreaking leadership in developing drugs that have saved and improved the lives of people with HIV/AIDS. 

Dr. Salgo received his Ph.D. from Mt. Sinai School of Medicine in New York and conducted post-doctoral fellowships at the University of Cambridge and Columbia University College of Physicians and Surgeons. He later received his MD from New York University School of Medicine, completed his internship and residency in Internal Medicine at the Bronx Municipal Hospital, and followed by specialty training in Infectious Diseases at Albert Einstein College of Medicine, also in New York.

Dr. Salgo is married to Roxann Garcia Salgo and they have one son, Seth.